We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Finds Efficacy, Safety Concerns Hinder Approvals for CNS Therapies
EMA Finds Efficacy, Safety Concerns Hinder Approvals for CNS Therapies
More than a third of the applications the EMA received for central nervous system candidates raised concerns about efficacy that hindered approvals, an analysis shows.